RxDoctor Payments Data

Zara Masood, MD

Psychiatry · Sault Sainte Marie, MINPI 1801220769

Payments from drug & device makers

$610in general payments, 2019–2025

Across 38 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$167
  • Otsuka America Pharmaceutical, Inc.$82
  • Johnson & Johnson$78
  • Neurocrine Biosciences, Inc.$66
  • Sunovion Pharmaceuticals Inc.$60
  • Teva Pharmaceuticals USA, Inc.$48
  • plus $110 from 3 others

What the payments were for

  • Food & beverage$610100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$610 in reported general payments places this provider in the 65th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$9,556
Medicare patients
31
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AristadaAripiprazole Lauroxil13$38,801
RexultiBrexpiprazole11$16,539
Vilazodone Hcl17$3,794
Lurasidone Hcl31$3,357
Aripiprazole37$1,842
Buspirone Hcl130$1,181
Methylphenidate ErMethylphenidate Hcl12$1,152
Desvenlafaxine Succinate ErDesvenlafaxine Succinate29$990
Bupropion XlBupropion Hcl52$832
Mirtazapine66$777
Duloxetine Hcl68$775
Quetiapine Fumarate82$514
Trazodone Hcl66$451
Lithium Carbonate ErLithium Carbonate32$449
Propranolol Hcl18$384

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada$167$38,80113 claims
Otsuka America Pharmaceutical, Inc.Rexulti$82$16,53911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Sault Sainte Marie

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →